306 related articles for article (PubMed ID: 3878153)
1. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
2. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
3. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
[TBL] [Abstract][Full Text] [Related]
4. The effect of age and sex on metabolism and urinary excretion of antipyrine.
Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
[TBL] [Abstract][Full Text] [Related]
5. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
St Peter JV; Abul-Hajj Y; Awni WM
Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
[TBL] [Abstract][Full Text] [Related]
7. Improved high-performance liquid chromatographic assay of antipyrine, hydroxymethylantipyrine, 4-hydroxyantipyrine and norantipyrine in urine.
Mikati MA; Szabo GK; Pylilo RJ; LeDuc BW; Browne TR; Greenblatt DJ
J Chromatogr; 1988 Dec; 433():305-11. PubMed ID: 3235560
[No Abstract] [Full Text] [Related]
8. Effect of chloroquine and primaquine on antipyrine metabolism.
Back DJ; Purba HS; Park BK; Ward SA; Orme ML
Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
Palette C; Cordonnier P; Naline E; Advenier C; Pays M
J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
[TBL] [Abstract][Full Text] [Related]
10. Antipyrine clearance and metabolism in patients with psoriasis.
Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolism in man: simultaneous determination of norantipyrine and 4-hydroxyantipyrine in urine by gas chromatography.
Inaba T; Fischer NE
Can J Physiol Pharmacol; 1980 Jan; 58(1):17-21. PubMed ID: 7378903
[TBL] [Abstract][Full Text] [Related]
13. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P
Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
[TBL] [Abstract][Full Text] [Related]
14. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine.
Brendel E; Meineke I; de Mey C
J Pharm Biomed Anal; 1989; 7(12):1783-90. PubMed ID: 2490567
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
16. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
17. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.
Teunissen MW; Meerburg-van der Torren JE; Vermeulen NP; Breimer DD
J Chromatogr; 1983 Dec; 278(2):367-78. PubMed ID: 6668316
[TBL] [Abstract][Full Text] [Related]
18. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
19. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
Jiang SX; Bayón JE; Ferre I; Mao XZ; González-Gallego J
Vet Parasitol; 2000 Mar; 88(3-4):177-86. PubMed ID: 10714456
[TBL] [Abstract][Full Text] [Related]
20. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]